Increased 30-Day Mortality Associated With Carbapenem-Resistant Enterobacteriaceae in Children
- PMID: 30338267
- PMCID: PMC6186173
- DOI: 10.1093/ofid/ofy222
Increased 30-Day Mortality Associated With Carbapenem-Resistant Enterobacteriaceae in Children
Abstract
In this multicenter study, we identified an increased risk of 30-day mortality among hospitalized children with carbapenem-resistant Enterobacteriaceae (CRE) isolated from clinical cultures compared with those with carbapenem-susceptible Enterobacteriaceae. We additionally report significant variation in antibiotic treatment for children with CRE infections with infrequent use of combination therapy.
Keywords: Gram-negative resistance; Klebsiella pneumoniae carbapenemase; multidrug-resistant organism; pediatrics.
References
-
- Montagnani C, Prato M, Scolfaro C, et al. ; Italian Society of Pediatric Infectious Diseases Carbapenem-resistant Enterobacteriaceae infections in children: an Italian Retrospective Multicenter Study. Pediatr Infect Dis J 2016; 35:862–8. - PubMed
-
- Nabarro LEB, Shankar C, Pragasam AK, et al. . Clinical and bacterial risk factors for mortality in children with carbapenem-resistant Enterobacteriaceae bloodstream infections in India. Pediatr Infect Dis J 2017; 36:e161–6. - PubMed
-
- Colombo S, Scolfaro C, Calitri C, et al. . Carbapenemase-producing Enterobacteriaceae (CPE) in the pediatric setting: results from an 18-month survey. Infect Control Hosp Epidemiol 2014; 35:599–601. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources